Brain cancer is an aggressive type of cancer that starts developing in the brain. There are many types of spinal cord and brain tumors, which can be either malignant or benign. Malignant brain tumors often grow and spread rather quickly into other tissues. The latest data from the National Cancer Institute shows that this year more than 24,000 individuals will be diagnosed with brain cancer and other cancers of the nervous system in America. SEER estimates that of this number, close to 19,000 individuals will succumb to this fatal disease, making up roughly 3% of all cancer deaths in the United States.
May is Brain Cancer Awareness month, so in an effort to raise more awareness about this disease, we look at some of the advancements made in the research and treatment of brain cancer. For starters, researchers have found that…
NOTE TO INVESTORS: The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company’s newsroom at https://ibn.fm/CNSP
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
BioMedWire is part of the InvestorBrandNetwork.